Orthofix Medical (OFIX) Competitors $14.58 -0.96 (-6.18%) Closing price 04:00 PM EasternExtended Trading$14.58 -0.01 (-0.03%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OFIX vs. IART, ATRC, ATEC, SRDX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include Integra LifeSciences (IART), AtriCure (ATRC), Alphatec (ATEC), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Orthofix Medical vs. Integra LifeSciences AtriCure Alphatec Surmodics AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Orthofix Medical (NASDAQ:OFIX) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, community ranking, earnings, dividends and profitability. Is OFIX or IART more profitable? Integra LifeSciences has a net margin of -0.42% compared to Orthofix Medical's net margin of -15.18%. Integra LifeSciences' return on equity of 12.35% beat Orthofix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Orthofix Medical-15.18% -21.25% -13.29% Integra LifeSciences -0.42%12.35%4.82% Does the media favor OFIX or IART? In the previous week, Integra LifeSciences had 11 more articles in the media than Orthofix Medical. MarketBeat recorded 12 mentions for Integra LifeSciences and 1 mentions for Orthofix Medical. Integra LifeSciences' average media sentiment score of 0.69 beat Orthofix Medical's score of -0.58 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Integra LifeSciences 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, OFIX or IART? Orthofix Medical has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Do analysts rate OFIX or IART? Orthofix Medical currently has a consensus price target of $23.33, suggesting a potential upside of 60.04%. Integra LifeSciences has a consensus price target of $23.00, suggesting a potential upside of 17.53%. Given Orthofix Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Orthofix Medical is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Integra LifeSciences 3 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.89 Which has preferable valuation and earnings, OFIX or IART? Integra LifeSciences has higher revenue and earnings than Orthofix Medical. Integra LifeSciences is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthofix Medical$799.49M0.71-$151.40M-$3.29-4.43Integra LifeSciences$1.61B0.94$67.74M-$0.09-217.44 Do insiders & institutionals believe in OFIX or IART? 89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 2.6% of Orthofix Medical shares are owned by insiders. Comparatively, 3.1% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor OFIX or IART? Integra LifeSciences received 20 more outperform votes than Orthofix Medical when rated by MarketBeat users. However, 62.20% of users gave Orthofix Medical an outperform vote while only 56.88% of users gave Integra LifeSciences an outperform vote. CompanyUnderperformOutperformOrthofix MedicalOutperform Votes41862.20% Underperform Votes25437.80% Integra LifeSciencesOutperform Votes43856.88% Underperform Votes33243.12% SummaryIntegra LifeSciences beats Orthofix Medical on 12 of the 18 factors compared between the two stocks. Remove Ads Get Orthofix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OFIX vs. The Competition Export to ExcelMetricOrthofix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$568.94M$4.01B$5.28B$7.12BDividend YieldN/A37.84%4.87%4.05%P/E Ratio-4.6627.4922.8817.49Price / Sales0.7145.47357.2285.14Price / CashN/A51.0838.1634.64Price / Book0.915.706.233.79Net Income-$151.40M$67.64M$3.20B$247.10M7 Day Performance-9.22%-8.60%-7.94%-7.28%1 Month Performance-14.29%-8.34%-2.92%-10.14%1 Year Performance2.75%5.42%3.65%-7.35% Orthofix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OFIXOrthofix Medical2.5055 of 5 stars$14.58-6.2%$23.33+60.0%+12.1%$568.94M$799.49M-4.661,090Positive NewsIARTIntegra LifeSciences3.3069 of 5 stars$21.99+1.4%$23.00+4.6%-40.8%$1.70B$1.61B-244.313,720ATRCAtriCure3.2514 of 5 stars$32.26+1.4%$49.44+53.3%+24.3%$1.58B$465.31M-33.961,300Short Interest ↑News CoverageGap DownATECAlphatec3.9583 of 5 stars$10.14-0.5%$17.67+74.2%-24.4%$1.46B$611.56M-7.92700Gap DownSRDXSurmodics4.1478 of 5 stars$30.53-0.7%$50.00+63.8%+11.7%$436.46M$125.45M-30.23450News CoverageANGOAngioDynamics4.2295 of 5 stars$9.39-1.2%$13.00+38.4%+61.5%$379.98M$286.50M-1.67760Earnings ReportNews CoverageARAYAccuray2.1664 of 5 stars$1.79-1.6%N/A-29.6%$184.07M$453.14M-35.801,040Gap DownRMTIRockwell Medical3.4405 of 5 stars$1.13-0.9%$4.00+254.0%-37.4%$38.48M$101.49M-22.60300RSLSReShape Lifesciences0.6719 of 5 stars$0.36-6.8%N/A-96.3%$1.19M$8.18M0.0050Gap UpHigh Trading VolumeABTAbbott Laboratories4.961 of 5 stars$132.76+1.5%$137.94+3.9%+18.2%$230.25B$41.95B17.35115,000Positive NewsISRGIntuitive Surgical4.7803 of 5 stars$495.27+0.7%$611.86+23.5%+29.0%$176.40B$8.35B77.2712,100Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies Integra LifeSciences Competitors AtriCure Competitors Alphatec Competitors Surmodics Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OFIX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthofix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.